Apoptosis of circulating lymphocyte in rats with unilateral ureteral obstruction: Role of angiotensin II

Nephrology

Volumn 10, Issue 5, 2005, Pages 464-469

  Eiam Ong, Somchit ^a   Udom, Janpen ^b   Sueblinvong, Tada ^a   Eiam Ong, Somchai ^a,c  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^b Boromarajionani College of Nursing   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Angiotensin II; Apoptosis; Circulating lymphocyte; Unilateral ureteral obstruction

Indexed keywords

ANGIOTENSIN; DIGOXIGENIN; DNA NUCLEOTIDYLEXOTRANSFERASE; ENALAPRIL; FLUORESCEIN; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; CIRCULATION; CONTROLLED STUDY; DRUG EFFECT; FLUORESCENCE MICROSCOPE; LYMPHOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; URETER OBSTRUCTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOPTOSIS; ENALAPRIL; LEUKOCYTE COUNT; LOSARTAN; LYMPHOCYTES; MALE; RATS; RATS, WISTAR; URETERAL OBSTRUCTION;

EID: 28444473408     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00440.x     Document Type: Article

References (41)

1. Yarger WE, Schocken DD, Harris HH. Obstructive nephropathy in the rat. J. Clin. Invest. 1980; 65: 400-12.
2. Pimentel JL, Martinez-Maldonado M, Wilcox JN, Wang S, Luo C. Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int. 1993; 44: 390-400.
3. Schreiner G, Harris K, Purkerson M, Klahr S. Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int. 1988; 34: 487-93.
4. Klahr S, Ishidoya S, Morrissey J. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am. J. Kidney Dis. 1995; 26: 141-6.
5. 1 in experimental hydronephrosis. Am. J. Physiol. 1994; 226: F926-33.
6. Wright EJ, McCaffery TA, Robertson AP, Vaughan ED, Felsen D. Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-β. Lab. Invest. 1996; 74: 528-37.
7. Truong LD, Petrusevska G, Yang G et al. Cell apoptosis and proliferation in experimental chronic uropathy. Kidney Int. 1996; 50: 200-7.
8. Truong LD, Sheikh-Hamad D, Chakraborty S, Duki WN. Cell apoptosis and proliferation in obstructive uropathy. Semin. Nephrol. 1998; 18: 641-51.
9. Klahr S. Obstructive nephropathy. Kidney Int. 1998; 54: 286-300.
10. Morrissey J, Klahr S. Enalapril decreased nuclear factor kB activation in the kidney with ureteral obstruction. Kidney Int. 1997; 52: 926-33.
11. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int. 1995; 47: 1285-94.
12. Satoh M, Kashihara N, Yamasaki Y et al. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J. Am. Soc. Nephrol. 2001; 12: 317-25.
13. Frokiaer J, Djurhuus JC, Nielsen M, Pederson EB. Renal hemodynamic response to ureteral obstruction during converting enzyme inhibition. Urol. Res. 1996; 24: 217-27.
14. El-Dahr SS, Gee J, Dipp S et al. Upregulation of renin angiotensin system and downregulation of kallikrein in obstructive nephropathy. Am. J. Physiol. 1993; 264: F874-81.
15. Boreham DR, Gale KL, Maves SR, Walker JA, Morrison DP. Radiation-induced apoptosis in human lymphocytes: Potential as a biological dosimeter. Health Phys. 1996; 71: 685-91.
16. Sueblinvong T, Pamutha P. Apoptotic activity in lymphocytes from radiation-treated cervical cancer patient. J. Med. Assoc. Thai. 2003; 86: 157-65.
17. Fuks Z, Persaud RS, Alfieri A et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 1994; 54: 2582-90.
18. Warters RL. Radiation-induced apoptosis in murine T-cell hybridoma. Cancer Res. 1992; 52: 883-90.
19. Ansari B, Coates PJ, Greestein BD, Hall PA. In situ end-labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol. 1993; 170: 1-8.
20. Kikuchi Y, Nonoguchi H, Mavhida K, Wakamatsu S, Koga H, Tomita K. Regulation of the apoptosis-related genes, Bax and Bcl-2, in the early stage of diabetes mellitus. Nephrology 2002; 7: 294-302.
21. Fang C, Yen C, Tsai T, Chen R, Lee P, Tomino Y. Antibiotics induce apoptosis of human peritoneal mesothelial cells. Nephrology 2003; 8: 144-9.
22. Pimentel JL, Montero A, Wang S et al. Sequential changes in renal expression of renin-angiotensin system gene in acute unilateral ureteral obstruction. Kidney Int. 1995; 48: 1247-53.
23. Klahr S. Urinary tract obstruction. Semin. Nephrol. 2001; 21: 133-45.
24. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. 2002; 283: F861-75.
25. Ravassa S, Fortuno MA, Gongalez A et al. Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneous hypertensive rats. Hypertension 2000; 36: 1065-71.
26. Fortumo MA, Ravassa S, Etayo JC, Diez J. Overexpression of Bax protein and enchanced apoptosis in the left ventricle of spontaneously hypertensive rats: Effects of AT1 blockade with losartan. Hypertension 1998; 32: 280-86.
27. Adams JW, Brwon JH. G-proteins in growth and apoptosis: Lessons from the heart. Oncogene 2001; 20: 1626-34.
28. Diep QN, El Mabouk M, Yue P, Schifferin EL. Effect of AT (1) receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension. Am. J. Physiol. 2002; 282: H1635-41.
29. Papp M, Li X, Zhuang J, Wang R, Uhal BD. Angiotensin receptor subtype AT (1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am. J. Physiol. 2002; 282: L713-18.
30. Rossig L, Hermann C, Haendeler J et al. Angiotensin II-induced upregulation of MAP kinase phosphatase-3 mRNA levels mediates endothelial cell apoptosis. Basic Res. Cardiol. 2002; 97: 1-8.
31. Nataraj C, Oliverio M, Mannon R et al. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J. Clin. Invest. 1999; 104: 1693-701.
32. Simon MR, Weinstock JV. Angiotensin II inhibition of mitogen- and antigen-induced human blood mononuclear cell thymidine uptake. J. Clin. Lab. Immunol. 1985; 18: 141-4.
33. Simon MR, Engel DE, Weinstock JV, Roi LD. The effect of angiotensin II on human mononuclear cell reactivity: Suppression of PHA-P-induced thymidine incorporation. Immunol. Invest. 1985; 14: 389-400.
34. Morrissey JJ. Angiotensin II: An immune costimulator? Am. J. Kidney Dis. 2000; 36: 434-40.
35. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem. J. 1993; 290: 33-40.
36. Odaka C, Mizuochi T. Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals. Clin. Exp. Immunol. 2000; 121: 515-22.
37. Shao J, Nangaku M, Miyata T et al. Imbalance of T-cell subsets in angiotensin II -infused hypertensive rats with kidney injury. Hypertension 2003; 42: 31-8.
38. Susuki Y, Ruiz-Oratega M, Gomez-Guerrero C, Tomino Y, Egido J. Angiotensin II, the immune system and renal diseases: Another road for RAS? Nephrol. Dial. Transplant. 2003; 18: 1423-6.
39. Defranco AL, Weiss A. Lymphocyte activation and effector functions. Curr. Opin. Immunol. 1998; 10: 243-67.
40. Rudin C, Dongen J, Thompson C. Apoptosis signalling in lymphocytes. Curr. Opin. Hematol. 1996; 3: 35-40.
41. Genestier L, Bonnefony-Berade N, Revillard J. Apoptosis of activated peripheral T cells. Transplant. Proc. 1999; 31: S33-8.